GlassScriptPhysician profile
Raoul Perez
NPI 1285697615
$1,028.52
in general payments reported to CMS, 2019-2025
17 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $42.46 · 2022: $269 · 2023: $308 · 2024: $170 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $717.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $355.84 | 2022-2025 | Trelegy Ellipta, Arexvy, Bexsero |
| Dexcom, INC. | $97.88 | 2024-2025 | Dexcom G6 Transmitter |
| Cardiovascular Systems INC. | $84.75 | 2022 | |
| Mylan Specialty L.P. | $80.64 | 2021-2024 | Yupelri |
| Viatris Specialty LLC | $62.97 | 2025 | Yupelri |
| Abbvie INC. | $59.43 | 2021-2023 | |
| Astellas Pharma US INC | $47.12 | 2025 | Veozah |
| Supernus Pharmaceuticals, INC. | $37.14 | 2022 | |
| Sanofi Pasteur INC. | $30.83 | 2023 | |
| Exact Sciences Corporation | $29.77 | 2023-2024 | Cologuard Collection Kit |
| Alnylam Pharmaceuticals INC. | $28.90 | 2023 | Oxlumo |
| Pfizer INC. | $28.46 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.22 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.44 | 2024 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $15.13 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $13.30 | 2022 | |
| Tactile Systems Technology INC | $12.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raoul Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.